Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine [1]

AIDS

Volumn 18, Issue 3, 2004, Pages 577-578

  Bonora, Stefano ^a   Boffito, Marta ^b   D'Avolio, Antonio ^a   Sciandra, Mauro ^a   Caci, Anna Maria ^a   Conta, Francesca ^a   Sinicco, Alessandro ^a   De Rosa, Francesco G ^a   Di Perri, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; STAVUDINE; ZIDOVUDINE;

BLOOD SAMPLING; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STATISTICAL SIGNIFICANCE;

ANTI-HIV AGENTS; DRUG MONITORING; HIV INFECTIONS; HUMANS; STAVUDINE; ZIDOVUDINE;

EID: 1642407572     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200402200-00031     Document Type: Letter

References (5)

1. Becher F, Pruvost AG, Schlemmer DD, Creminon CA, Goujard CM, Delfraissy JF, et al. Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients. AIDS 2003; 17:555-561.
2. Simon VA, Thiam MD, Lipford LC. Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography. J Chromatogr 2001; 913:447-453.
3. Legrand M, Goujard C, Mentrè F, Diquet B, Taburet AM, and the Cophart-ANRS102 Study Group. Nucleoside reverse transcriptase inhibitors plasma concentrations in patients with sustained virological response on HAART. In: 4th International Workshop on Clinical Pharmacology of HIV Therapy. Cannes, 27-29 March 2003 [Abstract 30:P5.5].
4. Shulman NS, Machekankano RA, Shafer RW, Winters MA, Zolopa AR, Liou SH, et al. Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. J Acquired Immune Defic Syndr 2001; 27:377-380.
5. Cote HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002; 346:811-820.